Method of adapting in-vitro models to aid in noninvasive glucose determination
First Claim
1. A computer implemented method for noninvasively estimating an analyte concentration with an in-vivo instrument system, comprising the steps of:
- providing a first model;
removing at least one interference from said first model to form a second model;
standardizing said in-vivo instrument system to said second model to generate a third model;
providing an in-vivo test set, comprising;
at least one in-vivo test signal; and
a reference analyte concentration corresponding with said in-vivo test signal;
applying said third model to said in-vivo test signal to generate a test value;
applying a correction to said third model using said test value and said reference analyte concentration to yield a corrected third model;
providing an in-vivo measurement signal; and
estimating and providing for use said analyte concentration using said corrected third model and said in-vivo measurement signal.
5 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to a noninvasive analyzer and a method of using information determined at least in part from in-vitro spectra of tissue phantoms or analyte solutions to aid in the development of a noninvasive glucose concentration analyzer and/or in the analysis of noninvasive spectra resulting in glucose concentration estimations in the body. The preferred apparatus is a spectrometer that includes a base module and a sample module that is semi-continuously in contact with a human subject and that collects spectral measurements which are used to determine a biological parameter in the sampled tissue, such as glucose concentration. Collection of in-vitro samples is, optionally, performed on a separate instrument from the production model allowing the measurement technology to be developed on a research grade instrument and used or transferred to a target product platform or production analyzer for noninvasive glucose concentration estimation.
-
Citations
66 Claims
-
1. A computer implemented method for noninvasively estimating an analyte concentration with an in-vivo instrument system, comprising the steps of:
-
providing a first model; removing at least one interference from said first model to form a second model; standardizing said in-vivo instrument system to said second model to generate a third model; providing an in-vivo test set, comprising; at least one in-vivo test signal; and a reference analyte concentration corresponding with said in-vivo test signal; applying said third model to said in-vivo test signal to generate a test value; applying a correction to said third model using said test value and said reference analyte concentration to yield a corrected third model; providing an in-vivo measurement signal; and estimating and providing for use said analyte concentration using said corrected third model and said in-vivo measurement signal. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
-
-
20. A computer implemented method for noninvasive estimation of a sample constituent property, comprising the steps of:
-
providing a noninvasive signal; providing a first model, wherein said first model comprises coefficients that are generated at least in part with an in-vitro data set, wherein said in-vitro data set comprises a spectrum of a tissue phantom having at least one optical parameter representative of said noninvasive signal in terms of photonic scattering and/or absorbance; standardizing an in-vivo instrument system to said first model, wherein a second model is generated; and estimating and providing for use said sample property by applying said second model to said noninvasive signal. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27, 28)
-
-
29. An apparatus for noninvasive estimation of a sample constituent property from a noninvasive spectrum, comprising:
-
an analyzer comprising a base module, a sample module, and a model residing in said analyzer; wherein said model comprises coefficients generated by standardizing an in-vivo system to an in-vitro data set, wherein said in-vitro data set comprises a spectrum of a tissue phantom having at least one optical parameter representative of said noninvasive spectrum in terms of photonic scattering and/or absorbance; and wherein said model is applied to said noninvasive spectrum for estimation of said sample constituent property. - View Dependent Claims (30)
-
-
31. A computer implemented method for noninvasive estimation of a sample constituent property, comprising the steps of:
-
providing a first model, wherein said first model comprises coefficients that are generated at least in part with an in-vitro data set; standardizing an in-vivo instrument system to said first model to generate a second model, wherein said second model comprises a second set of coefficients; providing an in-vivo test set, comprising; at least one in-vivo test signal; and a reference sample concentration that is correlated with said in-vivo test signal; applying said second model to said in-vivo test set to generate a test value; providing an in-vivo measurement signal; and estimating and providing for use said sample constituent property using said second model and said in-vivo measurement signal, wherein said step of estimating comprises multiplication of said in-vivo measurement signal by both a regression vector and a scaling factor resulting in a product that is adjusted with an offset. - View Dependent Claims (32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)
-
-
44. A computer implemented method for noninvasively estimating an analyte concentration, comprising the steps of:
-
providing a first calibration model; removing at least one interference from said first model to form a second model, wherein said first model comprises coefficients derived from data comprised of at least twenty percent in-vitro data, wherein said step of removing comprises projecting said coefficients onto a null space of said interference; providing an in-vivo signal; and estimating and providing for use said analyte concentration using said second model and said in-vivo signal. - View Dependent Claims (45, 46, 47, 48)
-
-
49. An apparatus for noninvasive estimation of a sample constituent property from a noninvasive spectrum, comprising:
an analyzer, comprising; a base module; a sample module; and a model residing in said analyzer; wherein said model comprises coefficients generated by standardizing an in-vivo system to a model of coefficients derived at least in part from an in-vitro data set; wherein said in-vitro signal comprises a spectrum of a tissue phantom having at least one optical parameter representative of said noninvasive spectrum in terms of photonic scattering and/or absorbance; and wherein said model is applied to said noninvasive spectrum to generate said sample constituent property. - View Dependent Claims (50, 51, 52, 53)
-
54. A computer implemented method for noninvasively estimating a blood/tissue glucose concentration, comprising the steps of:
-
providing a noninvasive near-infrared signal; providing a calibration model; supplementing said calibration model with an in-vitro signal, wherein said in-vitro signal comprises a spectrum of a tissue phantom having at least one optical parameter representative of said noninvasive near-infrared signal in terms of photonic scattering and/or absorbance; and estimating and providing for use said blood glucose concentration using said model and said noninvasive signal. - View Dependent Claims (55, 56, 57)
-
-
58. A computer implemented method for noninvasive estimation of a sample constituent property from an in-vivo instrument system, comprising the steps of:
-
providing a noninvasive signal; providing a model, comprising coefficients generated at least in part with an in-vitro data set, wherein said in-vitro data set comprises a spectrum of a tissue phantom having at least one optical parameter representative of said noninvasive spectrum in terms of photonic scattering and/or absorbance; standardizing said model to said in-vivo instrument system; and estimating and providing for use said sample property by applying said model to said noninvasive signal. - View Dependent Claims (59, 60, 61, 62, 63, 64, 65, 66)
-
Specification